Third Point’s Merck MRK Stock Holding History

Third Point’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,908,200	Closed	-$212M	–	34
2018 Q4	$212M	Sell	2,908,200 -1,807,800	-38%	-$128M	3.26%	10
2018 Q3	$319M	Buy	+4,716,000	New	+$300M	2.23%	15

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Third Point's MRK Position: Q1 2019 in Review

Third Point sold out of Merck (MRK) in Q1 2019, closing a stake of 2,908,200 shares — an estimated $212M sold.

Third Point first reported a position in MRK in Q3 2018 and held it in 2 quarters. The position peaked at $319M in Q3 2018. 2,292 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

Third Point reported no remaining Merck position as of Q1 2019 after selling out during the quarter.
Third Point sold 2,908,200 Merck shares in Q1 2019, an estimated $212M.
Third Point first reported a position in Merck in Q3 2018 and held it in 2 quarters.
Third Point's Merck position peaked at $319M in Q3 2018.
2,292 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Third Point's 13F filing for Q1 2019, filed 15 May 2019.